Trial record 1 of 1 for:    PSK breast cancer seattle
Previous Study | Return to List | Next Study

Vaccine Therapy and Trastuzumab With or Without Polysaccharide-K in Treating Patients With Stage IV HER2 Positive Breast Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2014 by University of Washington
Sponsor:
Collaborators:
Information provided by (Responsible Party):
University of Washington
ClinicalTrials.gov Identifier:
NCT01922921
First received: August 1, 2013
Last updated: June 26, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)